S&P Futures
5,903.00 -3.00 (-0.05%) Dow Futures
43,534.00 +16.00 (+0.04%) Nasdaq Futures
20,453.00 -30.50 (-0.15%) Russell 2000 Futures
2,292.10 +0.90 (+0.04%) Crude Oil
69.52 +0.30 (+0.43%) Gold
2,742.80 +12.80 (+0.47%)
Conavi Medical Corp. (TMDIF)
| Previous Close | 0.0327 |
| Open | 0.0322 |
| Bid | 0.0321 x 0 |
| Ask | 0.0400 x 0 |
| Day's Range | 0.0322 - 0.0400 |
| 52 Week Range | 0.0295 - 1.0000 |
| Volume | |
| Avg. Volume | 53,885 |
| Market Cap | 93.228M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2500 |
| Earnings Date | Oct 31, 2024 - Nov 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination
TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“the “Resulting Issuer” or the “Corporation”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the previously announced business combination between Conavi Medical Inc. (“Conavi”) and the Corporation in an all-stock transaction, which constituted a reverse takeover of the Corporation (the “Transaction”). The combined company (the Resulting Issuer) will focus on continuing to commercia
GlobeNewswireTitan Announces the Closing of Conavi’s Private Placement of Subscription Receipts and Provides Update on the Transaction
TORONTO, Ontario, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that, in connection with its amalgamation agreement (“Amalgamation Agreement”) with Conavi Medical Inc. (“Conavi”) providing for the combination of the companies in an all-stock transaction (the “Transaction”), Conavi has closed its previously announced concurrent private placement of subscription receipts (“Subscription Receipts”) for gross proceeds of US$7.7 million (t
